New Titan Medical CEO tasked with keeping Chapel Hill firm on track to commercialization


The public company is under new leadership as it works to advance its surgical system to clinical trials and keep its stock from being delisted.

Previous Hillsborough Street in Raleigh loses two restaurants, plenty of character amid rapid change
Next In Colorado, markup on homes with a view second only to California